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An online 14-question survey (REDCap.com) was created and 
distributed to physicians, physician assistants, and nurse 
practitioners affiliated with the Department of Neurology. 
The questionnaire addressed current referral patterns, the 
awareness of the in-office infusion center, concerns 
regarding referrals, rating of confidence in referring to the 
in-office infusion center, and if the staff wishes to have 
automated referrals to the treatment site. Information was 
gathered from infusion staff through in-person interviews to 
address concerns about the infusion enter. Cost of an 
infusion experience at the MPA and in-office infusion center 
was gathered from correspondence with the billing 
department. Cost of the infusions prior to insurance were 
compared. Data from the survey and interviews were 
presented at a neurology conference in a video-
recorded Powerpoint presentation with pamphlet 
distribution. Pamphlets were designed as summaries of the 
presentation and served as a concrete educational reference 
for staff. The number of completed infusions at the in-office 
infusion center during a 3-month period of November - 
January of 2017 and 2018 were compared to the number of 
infusions from the post-intervention period of November 
2018 - January 2019. Comparison of the pre-interventional 
and post-interventional data points were used as a 
measurement of the efficacy of the intervention and were 
translated to estimated cost savings by using the in-office 
infusion center. 
The educational intervention was successful when looking at  
the number of completed infusions before and after the 
intervention. The number of infusions on a monthly basis 
showed that there was an increasing trend upward from 
November 2018, following the educational intervention 
(Graph 1). The average infusions per month at the in-office 
infusion center increased by more than 8-fold, from 0.83 to 
7 (Graph 2). Billing data showed that the MPA was more 
expensive than the in-office infusion center, mainly due to 
added facility fees (Table 1). An example cost of a relapse 
infusion was much lower for the in-office infusion center 
(Graph 3). When the total billed cost per relapse treatment 
was multiplied by the post-interventional number of 
infusions/month, the potential cost-savings of using the in-
office infusion center as opposed to the MPA was $12,026.00 
in savings per month (Graph 4). Due to the success of this 
intervention and potential cost-savings, future targeted 
educational interventions with pre-assessment surveys would 
likely be a promising model to further establish improved use 
of the infusion center. A future automated referral option for 
the in-office infusion center for providers would likely be the 
next step forward.
Multiple Sclerosis (MS) is a chronic inflammatory disease that 
is characterized by demyelinating lesions throughout the 
central nervous system that unpredictably occur at different 
sites at different times. It affects approximately 400,000 
people in the United States and 2.1 million people 
worldwide.1 LVPG Neurology houses its own outpatient 
infusion center, the CAHC LVPG Neurology Infusion Center, to 
treat acute relapses for its MS patients with IV Solu-Medrol. 
Currently, there is a low number of neurologist referrals for 
IV Solu-Medrol infusion treatments for multiple sclerosis to 
this in-office infusion center compared to its main 
competing outpatient site - the Multipurpose Area (MPA), an 
infusion center located in the LVHN Cancer Center of the 
main hospital. It has had little publicity to the referring staff 
since its establishment in 2013. Records indicate that from 
November 2016 - January 2017, only 4 infusions were done at 
the outpatient infusion clinic. From November 2017 - January 
2018, only 1 infusion was completed. With approximately 1 
infusion or less per month across the past two years, 
facilities are largely underutilized (Graph 1). Based on the 
cost of infusions for a relapse treatment prior to insurance 
coverage, the in-office infusion center may be a more cost-
effective alternative to the MPA. 
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Graph 4: Estimated Average Monthly Billed Cost of In-
Office Infusions vs. MPA Infusions (Prior to Insurance) 









MPA In-Office Infusion Center
$945.00
$12,971.00
Table 1: Billing of Solu-
Medrol Infusions
Outpatient Infusion Center MPA
IV Solu-Medrol $135.00 $188.00
Infusion Products n/a $65 x 2
Facility Fees/ Infusion Cost n/a $1535
Total Cost $135.00 $1853
Insurance Coverage Full Coverage Full Coverage
Graph 3: Total Cost Comparison of In-office Infusion 
Center vs. MPA: Example of Total Billed for a Relapse 











MPA In-office Infusion Center
$135.00
$1,853.00























The in-office infusion center, according to infusion center 
staff, is more patient-centered when compared to the 
services at the MPA. It has a higher staff to patient ratio and 
gives a more personalized experience with a drawn curtain 
for privacy, a room for only two patients, and musical or 
televised entertainment. This is in comparison to the MPA, 
which is an open facility where little privacy is given. There 
is less nursing attention to each patient, due to the higher 
frequency of usage by patients at a time. For the patient, it 
may be a more satisfactory experience to use the in-office 
infusion center with no difference in cost to them, as all 
currently known insurances cover the treatments. In SELECT, 
the focus of healthcare on the patient is essential. It is 
important for the provider to know the patient’s values so 
that he or she can utilize a treatment that allows the patient 
to feel most comfortable. Values-based-patient-centered-
care (VBPCC) can be used to identify if a patient would 
benefit from using the in-office infusion center, rather than 
the MPA. From a health systems perspective, it is important 
to evaluate cost-effectiveness and utilizing facilities 
efficiently. The in-office infusion center was found to be less 
expensive in total billing prior to insurance compared to the 
MPA. With the difference in cost, the in-office infusion 
center would be the more cost-effective option.
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The purpose of this project is to increase the usage of 
the CAHC LVPG Neurology Outpatient Infusion Center for 
IV Solu-Medrol infusions by MS patients through a 
targeted educational presentation and pamphlet for 
referring physicians, physician’s assistants, and nurse 
practitioners.
In-Office Infusion Center 
4th Floor CAHC LVPG Neurology (Green Pod)
